Experiments also validate this point.
In order to validate this point of view, further clinical evidence is needed.
According the results from the deterministic sensitivity analysis developed, the model seems to be quite robust, but probabilistic sensitivity analyses would have provided additional information to validate this point.
To validate this point, we analyzed an etk-deficient strain.
In addition to fluorescence microscopy, we used two different EM techniques to validate this point and rule out potential sensitivity problems.
Further studies with large cohorts are necessary to validate this point.
To validate this point, Tra-1-60-positive FUCCI-hESCs sorted into early G1 or late G1 were grown in conditions inductive for endoderm differentiation for 12 hr and then for an additional 72 hr in conditions inductive for neuroectoderm differentiation.
We validated this cutoff point by testing its discriminating ability on a nonoverlapping cohort of patients described previously [ 16].
If the authors tried different cutoff points, one could argue that the authors should have used an independent validation set to validate this cutoff point.
